About Radialogica
Radialogica is a company based in Clayton (United States) founded in 2011. It operates as a HealthTech, SaaS (Software-as-a-Service), and Professional Services. Radialogica has raised $4.2 million across 2 funding rounds from investors including Holton Capital Group and St. Louis Arch Angels. The company has 17 employees as of December 31, 2022. Radialogica offers products and services including SciMoCa, fullAccess, and Clinical Trials Services. Radialogica operates in a competitive market with competitors including GenomOncology, ONCOHOST, Geneseeq, Sipai Wangluo and Protyon, among others.
- Headquarter Clayton, United States
- Employees 17 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Radialogics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.2 M (USD)
in 2 rounds
-
Latest Funding Round
$2.85 M (USD), Series A
Mar 15, 2016
-
Investors
Holton Capital Group
& 1 more
-
Employee Count
17
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Radialogica
Radialogica offers a comprehensive portfolio of products and services, including SciMoCa, fullAccess, and Clinical Trials Services.
Software for Monte-Carlo dose calculation and beam modeling.
Platform for radiotherapy data display and analysis sharing.
Quality management for radiotherapy in oncology clinical trials.
Funding Insights of Radialogica
Radialogica has successfully raised a total of $4.2M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.85 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Radialogica
Radialogica has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Holton Capital Group and St. Louis Arch Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in US tech and life sciences are targeted.
|
Locked | Locked | Locked | |
|
Early-stage businesses are funded by St. Louis Arch Angels.
|
Locked | Locked | Locked |
Investor details for Radialogica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Radialogica
Investment portfolio details for Radialogica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Radialogica
Detailed financials for Radialogica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Radialogica Comparisons
Peer comparison for Radialogica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Radialogica
Radialogica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenomOncology, ONCOHOST, Geneseeq, Sipai Wangluo and Protyon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic data is transformed into actionable insights for precision medicine.
|
|
| Locked | Locked | Locked |
AI-based proteomic analysis for oncology therapy planning is offered.
|
|
| Locked | Locked | Locked |
Personalized cancer treatments are delivered using genomic RNA profiling.
|
|
| Locked | Locked | Locked |
Delivers big data aggregation and analytics solutions for oncology.
|
|
| Locked | Locked | Locked |
Cancer therapeutics development and training programs are provided.
|
Detailed competitors of Radialogica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Radialogica
Complete news archive for Radialogica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Radialogica
Radialogica was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Radialogica is headquartered in Clayton, United States. It is registered at Clayton, Missouri, United States.
Radialogica is a funded company, having raised a total of $4.2M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Radialogica is 17.
Radialogica is engaged in providing software and services for radiation oncology, specifically targeting quality management in radiotherapy for cancer patients. The company operates within the healthtech sector, offering tools and insights to enhance treatment quality and patient outcomes. Solutions are utilized in clinical settings and trials, addressing variability in treatment planning and delivery. Services include radiotherapy quality assurance for oncology trials, partnering with pharmaceutical and biotech companies. Software products support clinical workflows, plan quality evaluation, and data analysis across global networks.
Radialogica's top competitors include ONCOHOST, GenomOncology and Geneseeq.
Radialogica offers SciMoCa, fullAccess, and Clinical Trials Services.
Radialogica has 2 investors. Key investors include Holton Capital Group, and St. Louis Arch Angels.